Billy Ng, Tenured Associate Professor at The Chinese University of Hong Kong, shared a post on LinkedIn:
“Delighted to share our recent review on sugar-based drug discovery, led by Stephan Scheeff and Jemma Arakelyan!
Open access link.
It is a privilege to contribute to a special issue celebrating the extraordinary glycoscience legacy of Prof. Chi-Huey Wong at Scripps Research. I am also very grateful to Mia H. at Scripps Research for the kind invitation.
We highlight how carbohydrate-based molecules have evolved from challenging synthetic targets into clinically important therapeutics, with impact across antivirals, SGLT2 inhibitors, and cancer vaccines. We hope this review will be useful to scientists and physicians working across drug discovery, medicinal chemistry, and clinical translation.”
Title: Carbohydrate-Based Drug Discovery: Synthetic Strategies and Clinical Applications
Authors: Stephan Scheeff, Jemma Arakelyan, Billy Wai-Lung Ng
Other articles featuring Stephan Scheeff and Jemma Arakelyan on OncoDaily.